SuggestSoft.com

Ipcombobox

IPComboBox OCX 1.0.0.1

IPComboBox OCX 1.0.0.1: The IPComboBox OCX control is a combobox control designed for IP Address input. IPComboBox to provide an instant verification of an entered address. Addresses can set to include leading zero`s and IPComboBox will automatically correct user enteries to the same format as they are entered. The IP address can be retrieved from the IPComboBox as one complete string or as individual parts of the IP address. IPComboBox can be configured to allow different list types as a normal combobox. Lists can include aliases which remove the




IPComboBox OCX 1.0.0.1: The IPComboBox OCX control is a combobox control designed for IP Address input.
IPComboBox OCX 1.0.0.1

IPComboBox to provide an instant verification of an entered address. Addresses can set to include leading zero`s and IPComboBox will automatically correct user enteries to the same format as they are entered. The IP address can be retrieved from the IPComboBox as one complete string or as individual parts of the IP address. IPComboBox can be configured to allow different list types as a normal combobox. Lists can include aliases which remove the

ip address, ipcombobox, combo, combobox, ipcombo, april16, address, alias




More Results: 1  

World IT News

  • PC Mall Chooses iZ3D 22-Inch Widescreen 3D MonitorsPopular 3D Monitor Now Features New Drivers for 64 Bit Compatibility, CrossFireX and Open GL Quad Buffer Support
  • New IBM Consulting Offerings Help Clients Be Greener, More EthicalImproving Corporate Social Responsibility Can Grow Revenue, Market Share
  • Are Your Computers Sky Divers?BURBANK, CA--(Marketwire - June 30, 2008) - Astute risk management defines success in theinsurance industry. Premiums charged to the company's customers reflectthat relation of risk to profit, while the riskiest ventures are avoidedentirely. Translating risk to the IT world would likely bring securitysoftware solutions to mind. Not managing those risks can result in dataloss, corporate espionage, and other nasty events. It may come as a surprise that file fragmentation can be risky businesstoo. Fragmentation creates many more unattractive side effects than a slowcomputer. The insurance policyholder who smokes is a higher risk than theone who does not, and subsequently they pay a higher premium.
  • Labwire Completes First Conversion of USIS BusinessHOUSTON, TX--(Marketwire - June 30, 2008) - Labwire, Inc. ( PINKSHEETS : LBWR ), a leadingprovider of employee screening solutions and canine security andsurveillance services, announced today that it has completed the firstconversion of business under the USIS agreement. "This is a very important accomplishment for us," commented Mr. DexterMorris, Chairman and Chief Executive Officer of Labwire. "Our team workedwell with USIS personnel, and the conversion was completed smoothly and onschedule. We are already planning the next interfaces and data transfersand exploring additional business possibilities with USIS. I am veryexcited about the potential of this strategic relationship."
  • FDAAdvisoryCommittee.com to Webcast the FDA Endocrinologic and Metabolic Drugs Advisory Committee Hearing on July 1st & 2nd in Conjunction With TalkPointNEW YORK, NY--(Marketwire - June 30, 2008) - TalkPoint , leading provider of theTools, Technology and Services for Interactive Internet Broadcasting, and FDAAdvisoryCommittee.com , the leadingwebcast and DVD source for FDA Advisory Committee Meetings, today announcedthat TalkPoint will be powering the Endocrinologic and Metabolic DrugsAdvisory Committee Meeting scheduled for July 1st & 2nd. The July Endocrinologic and Metabolic Drugs Advisory Committee Meeting isbeing held to further discuss whether to insist that new diabetes drugshave a positive impact on cardiovascular disease and life span. At issue iswhat benchmarks the FDA should use to approve diabetes drugs. The two-daymeeting of FDA officials and outside medical experts, set to start Tuesday,will discuss whether the agency should require additional, more rigorousbenchmarks, such as proof a drug ultimately lowers risks for cardiovasc